Prognostic factors in pediatric sepsis study, from the spanish society of pediatric intensive care

Pediatric Infectious Disease Journal

Volumn 33, Issue 2, 2014, Pages 152-157

  Pérez, David Vila ^a   Jordan, Iolanda ^a   Esteban, Elisabeth ^a   García Soler, Patricia ^b   Murga, Vega ^c   Bonil, Vanesa ^d   Ortiz, Irene ^e   Flores, Carlos ^f   Bustinza, Amaya ^g   Cambra, Francisco Jose ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

^e HOSPITAL VIRGEN DE LA SALUD   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

organ failure; PIRO; prognostic; sepsis; SIRS

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CONTROLLED STUDY; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HYPOTENSION; INCIDENCE; INFANT; INTENSIVE CARE; KIDNEY FAILURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; NEISSERIA MENINGITIDIS; NEUTROPENIA; NEUTROPHIL COUNT; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PURPURA; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SPAIN; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE COUNT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SPAIN;

EID: 84892958553     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/01.inf.0000435502.36996.72     Document Type: Article

References (69)

1. Piva JP, Celina García P, Bueno Campaña M, et al. Sepsis. In López-Herce Cid J, Calvo Rey C, Baltodano Agüero A, et al,eds. Manual de Cuidados Intensivos. 3th ed. Madrid Editorial Publimed. 2009287-296
2. Flores González JC, Varella Katz D, López-Herce Cid J. Shock. In López-Herce Cid J, Calvo Rey C, Baltodano Agüero A, et al, eds. Manual de Cuidados Intensivos. 3th ed. Madrid Editorial Publimed. 2009352-364
3. Forero J. Síndrome de disfunción multiorgánica múltiple. In López-Herce Cid J, Calvo Rey C, Baltodano Agüero A, et al, eds. Manual de Cuidados Intensivos. 3th ed. Madrid Editorial Publimed. 2009365-370
4. Dellinger RP, Levy MM, Carlet JM, et al.; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign international guidelines for management of severe sepsis and septic shock 2008.Crit Care Med. 2008;36296-327
5. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30536-555
6. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;62-8
7. Steven M, Opal SM. Concept of PIRO as a new conceptual framework to understand sepsis. Pediatr Crit Care Med. 2005;6(3 suppl)S55-S60
8. Angus DC, Burgner D, Wunderink R, et al. The PIRO concept P is for predisposition. Crit Care. 2003;7248-251
9. Vincent JL, Opal S, Torres A, et al. The PIRO concept I is for infection. Crit Care. 2003;7252-255
10. Gerlach H, Dhainaut JF, Harbarth S, et al. The PIRO concept R is for response. Crit Care. 2003;7256-259
11. Vincent JL, Wendon J, Groeneveld J, et al. The PIRO concept O is for organ dysfunction. Crit Care. 2003;7260-264
12. Moreno RP, Metnitz B, Adler L, et al.; SAPS 3 Investigators. Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med. 2008;34496-504
13. Howell MD, Talmor D, Schuetz P, et al. Proof of principle the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39322-327
14. Charles PE, Tinel C, Barbar S, et al. Procalcitonin kinetics within the first days of sepsis relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care. 2009;13R38
15. Blanco J, Muriel-Bombín A, Sagredo V, et al.; Grupo de Estudios y Análisis en Cuidados Intensivos. Incidence, organ dysfunction and mortality in severe sepsis a Spanish multicentre study. Crit Care. 2008;12R158
16. Wolfler A, Silvani P, Musicco M, et al.; Italian Pediatric Sepsis Study (SISPe) group. Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units a prospective national survey. Intensive Care Med. 2008;341690-1697
17. Graciano AL, Balko JA, Rahn DS, et al. The Pediatric Multiple Organ Dysfunction Score (P-MODS) development and validation of an objective scale to measure the severity of multiple organ dysfunction in critically ill children. Crit Care Med. 2005;331484-1491
18. Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score prospective, observational, multicentre study. Lancet. 2003;362192-197
19. Leteurtre S, Duhamel A, Grandbastien B, et al. Paediatric logistic organ dysfunction (PELOD) score. Lancet. 2006;367897-902
20. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunctionfailure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22707-710
21. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunctionfailure in intensive care units results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;261793-1800
22. Peres Bota D, Melot C, Lopes Ferreira F, et al. The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction. Intensive Care Med. 2002;28 1619-1624
23. Dellinger RP, Levy MM, Carlet JM, et al.; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign international guidelines for management of severe sepsis and septic shock 2008.Crit Care Med. 2008;36296-327
24. Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167695-701
25. Stoll BJ, Holman RC, Schuchat A. Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics. 1998;102e18
26. Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidalpermeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet. 2000;356961-967
27. Esteban E, Ferrer R, Urrea M, et al. The Impact of a Quality Improvement Intervention to Reduce Nosocomial Infections in a PICU. Pediatr Crit Care Med. 2013;14525-532
28. Urrea M, Pons M, Serra M, et al. Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr Infect Dis J. 2003;22490-494
29. González-Cortés R, López-Herce-Cid J, García-Figueruelo A, et al.[Prolonged stay in pediatric intensive care units mortality and healthcare resource consumption]. Med Intensiva. 2011;35417-423
30. Navoa-Ng JA, Berba R, Galapia YA, et al. Device-associated infections rates in adult, pediatric, and neonatal intensive care units of hospitals in the Philippines International Nosocomial Infection Control Consortium (INICC) findings. Am J Infect Control. 2011;39548-554
31. Stover BH, Shulman ST, Bratcher DF, et al.; Pediatric Prevention Network. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control. 2001;29152-157
32. Geffers C, Gastmeier P. Nosocomial infections and multidrug-resistant organisms in Germany epidemiological data from KISS (the Hospital Infection Surveillance System). Dtsch Arztebl Int. 2011;10887-93
33. Weber DJ, Raasch R, Rutala WA. Nosocomial infections in the ICU the growing importance of antibiotic-resistant pathogens. Chest. 1999;115(3suppl)34S-41S
34. L in MY, Hota B, Khan YM, et al.; CDC Prevention Epicenter Program. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA. 2010;3042035-2041
35. Cohen MJ, Benenson S. Surveillance quality in reporting nosocomial bloodstream infection rates. JAMA. 2011;305779-780; author reply 780
36. Wilkinson JD, Pollack MM, Glass NL, et al. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr. 1987;111324-328
37. Goh A, Lum L. Sepsis, severe sepsis and septic shock in paediatric multiple organ dysfunction syndrome. J Paediatr Child Health. 1999;35488-492
38. Tantaleán JA, León RJ, Santos AA, et al. Multiple organ dysfunction syndrome in children. Pediatr Crit Care Med. 2003;4181-185
39. Rivers E, Nguyen B, Havstad S, et al.; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;3451368-1377
40. Rady MY, Rivers EP, Nowak RM. Resuscitation of the critically ill in the ED responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med. 1996;14218-225
41. Cortez A, Zito J, Lucas CE, et al. Mechanism of inappropriate polyuria in septic patients. Arch Surg. 1977;112471-476
42. Elliott DC. An evaluation of the end points of resuscitation. J Am Coll Surg. 1998;187536-547
43. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;3331025-1032
44. Levy MM, Dellinger RP, Townsend SR, et al.; Surviving Sepsis Campaign. The Surviving Sepsis Campaign results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38367-374
45. Zahar JR, Timsit JF, Garrouste-Orgeas M, et al. Outcomes in severe sepsis and patients with septic shock pathogen species and infection sites are not associated with mortality. Crit Care Med. 2011;391886-1895
46. Daniels R, Nutbeam T, McNamara G, et al. The sepsis six and the severe sepsis resuscitation bundle a prospective observational cohort study. Emerg Med J. 2011;28507-512
47. Pollack MM, Ruttimann UE, Getson PR. Accurate prediction of the outcome of pediatric intensive care. A new quantitative method. N Engl J Med. 1987;316134-139
48. Espuñes SP, Cid JL-H, Galán CR, et al. [Prognostic indexes of mortality in pediatric intensive care units]. An Pediatr (Barc). 2007;66345-350
49. Costa GA, Delgado AF, Ferraro A, et al. Application of the pediatric risk of mortality (PRISM) score and determination of mortality risk factors in a tertiary pediatric intensive care unit. Clinics (Sao Paulo). 2010;65 1087-1092
50. Bellad R, Rao S, Patil VD, et al. Outcome of intensive care unit patients using Pediatric Risk of Mortality (PRISM) score. Indian Pediatr. 2009;46 1091-1092
51. van Keulen JG, Polderman KH, Gemke RJ. Reliability of PRISM and PIM scores in paediatric intensive care. Arch Dis Child. 2005;90211-214
52. Singhal D, Kumar N, Puliyel JM, et al. Prediction of mortality by application of PRISM score in intensive care unit. Indian Pediatr. 2001;38714-719
53. Bilan N, Galehgolab BA, Emadaddin A, et al. Risk of mortality in pediatric intensive care unit, assessed by PRISM-II. Pak J Biol Sci. 2009;12 480-485
54. Gemke RJ, van Vught J. Scoring systems in pediatric intensive care PRISM II versus PIM. Intensive Care Med. 2002;28204-207
55. Wang JN, Wu JM, Chen YJ. Validity of the updated pediatric risk of mortality score (PRISM II) in predicting the probability of mortality in a pediatric intensive care unit. Acta Paediatr Taiwan. 2001;42333-337
56. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;291303-1310
57. Blanco J, Muriel-Bombín A, Sagredo V, et al.; Grupo de Estudios y Análisis en Cuidados Intensivos. Incidence, organ dysfunction and mortality in severe sepsis a Spanish multicentre study. Crit Care. 2008;12R158
58. Finfer S, Bellomo R, Lipman J, et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 2004;30589-596
59. Bernard GR, Vincent JL, Laterre PF, et al.; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344699-709
60. Kyle UG, Coss Bu JA, Kennedy CE, et al. Organ dysfunction is associated with hyperglycemia in critically ill children. Intensive Care Med. 2010;36312-320
61. O'Brien JE Jr, Marshall JA, Tarrants ML, et al. Intraoperative hyperglycemia and postoperative bacteremia in the pediatric cardiac surgery patient. Ann Thorac Surg. 2010;89578-583; discussion 583
62. Jeschke MG, Kulp GA, Kraft R, et al. Intensive insulin therapy in severely burned pediatric patients a prospective randomized trial. Am J Respir Crit Care Med. 2010;182351-359
63. Jeschke MG, Kraft R, Emdad F, et al. Glucose control in severely thermally injured pediatric patients what glucose range should be the target Ann Surg. 2010;252521-527; discussion 527
64. Preissig CM, Rigby MR. Pediatric critical illness hyperglycemia risk factors associated with development and severity of hyperglycemia in critically ill children. J Pediatr. 2009;155734-739
65. Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38838-842
66. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105244-252
67. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87978-982
68. Moghissi ES, Korytkowski MT, DiNardo M, et al.; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;321119-1131
69. Leclerc F, Leteurtre S, Duhamel A, et al. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respir Crit Care Med. 2005;171348-353